These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 4154350)

  • 1. Drug therapy reviews: rational use of psychotropic drugs. III. Major tranquilizers.
    Greenblatt DJ; Shader RI
    J Maine Med Assoc; 1974 Oct; 65(10):251-6. PubMed ID: 4154350
    [No Abstract]   [Full Text] [Related]  

  • 2. Rational use of psychotropic drugs. III. Major tranquilizers.
    Greenblatt DJ; Shader RI
    Am J Hosp Pharm; 1974 Dec; 31(12):1226-31. PubMed ID: 4156455
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy.
    Stone WN; Hofling CK; Winslow WW
    Prog Neurol Psychiatry; 1968; 23():563-81. PubMed ID: 4890081
    [No Abstract]   [Full Text] [Related]  

  • 5. A PRELIMINARY STUDY OF P-5227, a new active tricyclic antipsychotic agent.
    Simpson GM; Iqbal J; Iqbal F; Angus JW
    Curr Ther Res Clin Exp; 1966 Oct; 8(10):465-71. PubMed ID: 4961022
    [No Abstract]   [Full Text] [Related]  

  • 6. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
    Degkwitz R; Bauer MP; Gruber M; Hampel G; Luxenburger O; Richartz M; Wenzel W
    Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological and neurochemical effects of clozapine (Leponex): new aspects in the drug therapy of schizophrenia].
    Bürki HR; Ruch W; Asper H; Baggiolini M; Stille G
    Schweiz Med Wochenschr; 1973 Dec; 103(48):1716-24. PubMed ID: 4753069
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced extrapyramidal symptoms: their incidence and treatment.
    Sheppard C; Merlis S
    Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of several psychotropic agents on changes in the behavior of mice induced by acetaldehyde].
    Andronova LM; Barkov NK; Vikhliaev IuI
    Farmakol Toksikol; 1978; 41(6):660-5. PubMed ID: 31298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

  • 11. A preliminary study of Thiothixene in chronic schizophrenics.
    Simpson GM; Iqbal J
    Curr Ther Res Clin Exp; 1965 Nov; 7(11):697-700. PubMed ID: 4953690
    [No Abstract]   [Full Text] [Related]  

  • 12. Withdrawal symptoms after long-term treatment with neuroleptics.
    Krystof J; Zyg J; Mitkiewicz S; Kaczyński J
    Pol Med J; 1972; 11(1):189-95. PubMed ID: 5040995
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients.
    Ananth JV; Horodesky S; Lehmann HE; Ban TA
    Laval Med; 1970 Sep; 41(7):934-8. PubMed ID: 5509491
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychotropic drugs used in the management of schizophrenia.
    Bueno JR; Himwich HE
    Int J Neurol; 1967; 6(1):77-93. PubMed ID: 5630202
    [No Abstract]   [Full Text] [Related]  

  • 15. [Carpipramine, a specific psychotropic drug between neuroleptics and anti-depressive drugs].
    Deniker P; Lôo H; Zarifian E; Garreau G; Benyacoub A; Roux JM
    Ann Med Psychol (Paris); 1978 Nov; 136(9):1069-80. PubMed ID: 378058
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 17. [New therapeutics import in clinical manifestations on alcoholism (author's transl)].
    Pignol F; Casanova P
    Sem Hop; 1979 Apr 8-15; 55(13-14):655-7. PubMed ID: 38510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of indication for use of antiparkinson medication. A follow-up study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    Dis Nerv Syst; 1971 Aug; 32(8):538-41. PubMed ID: 5094160
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
    Serafetinides EA; Clark ML
    Dis Nerv Syst; 1971 Aug; 32(8):567-71. PubMed ID: 5094163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.